A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma. (20th August 2015) - Mudigonda, Tejaswi V.; Wyman, Kenneth; Spigel, David R.; Dahlman, Kimberly B.; Greco, F. Anthony; Puzanov, Igor; Kelley, Mark C.; Hainsworth, John D.; Sosman, Jeffrey A.; Johnson, Douglas B.